ADMA BIOLOGICS, INC. (ADMA) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: -$4.62M2012: -$7.91M2013: -$15.04M2014: -$16.02M2015: -$15.51M2016: -$17.33M2017: -$39.31M2018: -$60.29M2019: -$41.42M2020: -$64.91M2021: -$58.37M2022: -$39.37M2023: $21.63M2024: $138.98M2025: $191.44M$191.44M
2011Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$191.44M+37.7%
2024$138.98M+542.5%
2023$21.63M+155.0%
2022-$39.37M+32.6%
2021-$58.37M+10.1%
2020-$64.91M-56.7%
2019-$41.42M+31.3%
2018-$60.29M-53.4%
2017-$39.31M-126.8%
2016-$17.33M-11.7%
2015-$15.51M+3.2%
2014-$16.02M-6.5%
2013-$15.04M-90.2%
2012-$7.91M-71.1%
2011-$4.62M